These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1996818)

  • 61. Relay: A Peer-Delivered Emergency Department-Based Response to Nonfatal Opioid Overdose.
    Welch AE; Jeffers A; Allen B; Paone D; Kunins HV
    Am J Public Health; 2019 Oct; 109(10):1392-1395. PubMed ID: 31415200
    [TBL] [Abstract][Full Text] [Related]  

  • 62. EMS naloxone administration as non-fatal opioid overdose surveillance: 6-year outcomes in Marion County, Indiana.
    Ray BR; Lowder EM; Kivisto AJ; Phalen P; Gil H
    Addiction; 2018 Dec; 113(12):2271-2279. PubMed ID: 30255531
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A descriptive study of racial and ethnic differences of drug overdoses and naloxone administration in Pennsylvania.
    Barboza GE; Angulski K
    Int J Drug Policy; 2020 Apr; 78():102718. PubMed ID: 32199352
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Heroin and pharmaceutical opioid overdose events: Emergency medical response characteristics.
    Banta-Green CJ; Coffin PO; Schoeppe JA; Merrill JO; Whiteside LK; Ebersol AK
    Drug Alcohol Depend; 2017 Sep; 178():1-6. PubMed ID: 28623805
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Take home naloxone and the prevention of deaths from opiate overdose: two pilot schemes.
    Dettmer K; Saunders B; Strang J
    BMJ; 2001 Apr; 322(7291):895-6. PubMed ID: 11302902
    [No Abstract]   [Full Text] [Related]  

  • 66. Administration of Naloxone by Prehospital Personnel: A Retrospective Analysis.
    Bowers KM; Shelton J; Cortez E; Lowe R; Casey J; Little A
    Cureus; 2019 Sep; 11(9):e5602. PubMed ID: 31700715
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Does paramedic-base hospital contact result in beneficial deviations from standard prehospital protocols?
    Hoffman JR; Luo J; Schriger DL; Silver L
    West J Med; 1990 Sep; 153(3):283-7. PubMed ID: 2219893
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Opioid overdose prevention with intranasal naloxone among people who take methadone.
    Walley AY; Doe-Simkins M; Quinn E; Pierce C; Xuan Z; Ozonoff A
    J Subst Abuse Treat; 2013 Feb; 44(2):241-7. PubMed ID: 22980450
    [TBL] [Abstract][Full Text] [Related]  

  • 69. FASTER RESPONSE. Hospitals backing increased use of opioid antidote.
    Asplund J
    Hosp Health Netw; 2016 Jan; 90(1):20, 22, 2. PubMed ID: 26904909
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Randomized controlled trial comparing the effectiveness and safety of intranasal and intramuscular naloxone for the treatment of suspected heroin overdose.
    Kerr D; Kelly AM; Dietze P; Jolley D; Barger B
    Addiction; 2009 Dec; 104(12):2067-74. PubMed ID: 19922572
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: a pilot intervention study.
    Seal KH; Thawley R; Gee L; Bamberger J; Kral AH; Ciccarone D; Downing M; Edlin BR
    J Urban Health; 2005 Jun; 82(2):303-11. PubMed ID: 15872192
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Intranasal administration of naloxone by paramedics.
    Barton ED; Ramos J; Colwell C; Benson J; Baily J; Dunn W
    Prehosp Emerg Care; 2002; 6(1):54-8. PubMed ID: 11789651
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Two cases of intranasal naloxone self-administration in opioid overdose.
    Green TC; Ray M; Bowman SE; McKenzie M; Rich JD
    Subst Abus; 2014; 35(2):129-32. PubMed ID: 24821348
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Another piece of the puzzle.
    Meador SA
    Acad Emerg Med; 1996 Jul; 3(7):657. PubMed ID: 8816179
    [No Abstract]   [Full Text] [Related]  

  • 75. Disparity in naloxone administration by emergency medical service providers and the burden of drug overdose in US rural communities.
    Faul M; Dailey MW; Sugerman DE; Sasser SM; Levy B; Paulozzi LJ
    Am J Public Health; 2015 Jul; 105 Suppl 3(Suppl 3):e26-32. PubMed ID: 25905856
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pharmacokinetic Properties and Human Use Characteristics of an FDA-Approved Intranasal Naloxone Product for the Treatment of Opioid Overdose.
    Krieter P; Chiang N; Gyaw S; Skolnick P; Crystal R; Keegan F; Aker J; Beck M; Harris J
    J Clin Pharmacol; 2016 Oct; 56(10):1243-53. PubMed ID: 27145977
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Opiate addiction and overdose: experiences, attitudes, and appetite for community naloxone provision.
    Barry T; Klimas J; Tobin H; Egan M; Bury G
    Br J Gen Pract; 2017 Apr; 67(657):e267-e273. PubMed ID: 28246098
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pulmonary Complications of Opioid Overdose Treated With Naloxone.
    Farkas A; Lynch MJ; Westover R; Giles J; Siripong N; Nalatwad A; Pizon AF; Martin-Gill C
    Ann Emerg Med; 2020 Jan; 75(1):39-48. PubMed ID: 31182316
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Rapid Naloxone Administration Workshop for Health Care Providers at an Academic Medical Center.
    Jawa R; Luu T; Bachman M; Demers L
    MedEdPORTAL; 2020 Feb; 16():10892. PubMed ID: 32175476
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Law enforcement attitudes toward overdose prevention and response.
    Green TC; Zaller N; Palacios WR; Bowman SE; Ray M; Heimer R; Case P
    Drug Alcohol Depend; 2013 Dec; 133(2):677-84. PubMed ID: 24051061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.